Whole-body T2* mapping at 1.5 T

Magnetic Resonance Imaging

Volumn 27, Issue 4, 2009, Pages 489-496

  Rossi, Cristina ^a   Boss, Andreas ^a   Haap, Michael ^a   Martirosian, Petros ^a   Claussen, Claus D ^a   Schick, Fritz ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Iron overload; T2* relaxation; Whole body MRI

Indexed keywords

FERRITIN; IRON; IRON CHELATING AGENT;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CHELATION THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FERRITIN BLOOD LEVEL; GRAY MATTER; HUMAN; HUMAN TISSUE; IRON OVERLOAD; KIDNEY; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; SKELETAL MUSCLE; SPLEEN; VOLUNTEER; WHITE MATTER; WHOLE BODY IMAGING; ALGORITHM; BETA THALASSEMIA; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; ALGORITHMS; BETA-THALASSEMIA; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

EID: 63349091688     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2008.08.004     Document Type: Article

References (28)

1. Kellenberger C.J., Miller S.F., Khan M., Gilday D.L., Weitzman S., and Babyn P.S. Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol 14 (2004) 1829-1841
2. Schlemmer H.P., Schafer J., Pfannenberg C., Radny P., Korchidi S., Müller-Horvat C., et al. Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 40 (2005) 64-71
3. Schmidt G.P., Schoenberg S.O., Reiser M.F., and Baur-Melnyk A. Whole-body MR imaging of bone marrow. Eur J Radiol 55 (2005) 33-40
4. Boss A., Martirosian P., Kueper K., Fierlbeck G., Claussen C.D., and Schick F. Whole-body magnetization transfer contrast imaging. J Magn Reson Imaging 24 (2006) 1183-1187
5. Haacke M., Brown R., Thompson M., and Venkatesan R. Magnetic resonance imaging. Physical principles and sequence design (1999), John Wiley & Sons, New York
6. Atlas S.W., Mark A.S., Grossman R.I., and Gomori J.M. Intracranial hemorrhage: gradient-echo MR imaging at 1.5T. Comparison with spin-echo imaging and clinical applications. Radiology 168 (1988) 803-807
7. Mack M.G., Balzer J.O., Straub R., Eichler K., and Vogl T.J. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 222 (2002) 239-244
8. Gandon Y., Guyader D., Heautot J.F., Reda M.I., Yaouanq J., Buhé T., et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 193 (1994) 533-538
9. Schenck J.F. The role of magnetic susceptibility in magnetic resonance imaging: MRI compatibility of the first and second kinds. Med Phys 23 (1996) 815-850
10. Beutler E., Felitti V., Ho N.J., and Gelbart T. Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease. Acta Haematol 107 (2002) 145-149
11. Schmidt G.P., Wintersperger B., Graser A., Baur-Melnyk A., Reiser M.F., and Schoenberg S.O. High-resolution whole-body magnetic resonance imaging application at 1.5 and 3 Tesla: a comparative study. Invest Radiol 42 (2007) 449-459
12. Schick F. Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 15 (2005) 946-959
13. Machann J., Haap M., Liebig G., Claussen C.D., Häring H.U., Fritsche A., et al. Susceptibility weighted MRI of liver and spleen correlates with serum ferritin concentrations in healthy volunteers and visualizes changes after phlebotomy in patients with hemochromatosis. Eur Radology 17 Suppl 3 (2007) C50
14. Bartzokis G., Tishler T.A., Lu P.H., Villablanca P., Altshuler L.L., Carter M., et al. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28 (2007) 414-423
15. Xu X., Wang Q., and Zhang M. Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage 40 (2008) 35-42
16. Anderson L.J., Holden S., Davis B., Prescott E., Charrier C.C., Bunce N.H., et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22 (2001) 2171-2179
17. Wood J.C., Enriquez C., Ghugre N., Tyzka J.M., Carson S., Nelson M.D., et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106 (2005) 1460-1465
18. Westwood M.A., Anderson L.J., Firmin D.N., Gatehouse P.D., Lorenz C.H., Wonke B., et al. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 18 (2003) 616-620
19. Peters A.M., Brookes M.J., Hoogenraad F.G., Gowland P.A., Francis S.T., Morris P.G., et al. T2* measurements in human brain at 1.5, 3 and 7 T. Magn Reson Imaging 25 (2007) 748-753
20. Graham J.M., Paley M.N.J., Gruenewald R.A., Hoggard N., and Griffiths P.D. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123 (2000) 2423-2431
21. Miszkiel K.A., Paley M.N.J., Wilkinson I.D., Hall-Craggs M.A., Ordidge R., Kendall B.E., et al. The measurement of R2, R2*, and R2′ in HIV-infected patients using the prime sequence as a measure of brain iron deposition. Magn Reson Imaging 15 (1997) 113-119
22. Chirnomas S.D., Geukes-Foppen M., Barry K., Braunstein J., Kalish L.A., Neufeld E.J., et al. Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias. Am J Hematol (2008) 10.1002/ajh.21221
23. Di Tucci A.A., Matta G., Deplano S., Gabbas A., Depau C., Derudas D., et al. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica (2008) 10.3324/haematol.12759
24. Lam W.W., Au W.Y., Chu W.C., Tam S., Ha S.Y., and Pennell D.J. One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients. J Magn Reson Imaging 28 (2008) 29-33
25. Haacke M.E., Cheng N.Y.C., House M.J., Liu Q., Neelavalli J., Ogg R.J., et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23 (2005) 1-25
26. Schenck J.F. Magnetic resonance imaging of brain iron. J Neurol Sc 207 (2007) 99-102
27. Borgna-Pignatti C., Rugolotto S., De Stefano P., Zhao H., Cappellini M.D., Del Vecchio G.C., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89 (2004) 1187-1193
28. Reichenbach J.R., Venkatesan R., Yablonskiy D.A., Thompson M.R., Lai S., and Haacke E.M. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging 7 (1997) 266-279